Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05569915 · ClinicalTrials.gov registry record · NA
Project QueST 2023: Queer Survivors of Trauma
A NA study of Stress Disorders, Post-Traumatic and Drinking Heavy, sponsored by Syracuse University.
- Completed
- Registry status
- NA
- Development phase
- 131
- Enrollment target
- 1
- Study location
NCT05569915: Completed NA study of Stress Disorders, Post-Traumatic and Drinking Heavy, sponsored by Syracuse University.
NCT05569915 is a NA study of Stress Disorders, Post-Traumatic and Drinking Heavy that has completed, run by Syracuse University. The registered enrollment target is 131 participants, below the 154-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (15% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05569915, a NA study of Stress Disorders, Post-Traumatic and Drinking Heavy, has completed, sponsored by Syracuse University.
- COMPLETED
- Registry status
- NA
- Development phase
- 131 participants
- Enrollment target
- 1
- Study location
Study Summary
This study aims to test the initial efficacy of tailored online writing interventions specifically designed for sexual minority women, transgender individuals, and/or nonbinary people to target the primary outcomes: posttraumatic stress disorder (PTSD) symptom severity and hazardous drinking.
Primary Outcome
Posttraumatic stress disorder (PTSD) symptoms will be measured with the Psychometric Properties of the Posttraumatic Diagnostic Scale for DSM-5 (PDS-5). The PDS-5 is a 24-item self-report measure designed to assess the severity of DSM-5 PTSD symptoms. The 24-item scale comprises a checklist of traumatic event types the individual has experienced, identification of the most distressing traumatic event, and an assessment of PTSD symptoms. The assessment of PTSD symptoms yields a total score and th
Conditions Studied
Interventions
- BEHAVIORAL Control
- BEHAVIORAL Trauma Expressive Writing
- BEHAVIORAL Stigma Expressive Writing
Study Locations (1)
New York
- Syracuse University - Syracuse
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 131 participants |
| Start Date | 2023-06-01 |
| Est. Completion | 2024-11-30 |
| Phase | NA |
What the finished NCT05569915 record still lists
NCT05569915 is an interventional study that assigns participants to a tested intervention. The registered 131 participants enrollment target is mid-sized for trials with a published cap, below the 154-participant average among 66 other Stress Disorders, Post-Traumatic trials with a reported enrollment target (15% lower).
The record links to 2 conditions, with Stress Disorders, Post-Traumatic appearing as the primary indexed condition, and to 3 interventions - of which Control is the first listed.
NCT05569915 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05569915 about?
NCT05569915 is a clinical study titled "Project QueST 2023: Queer Survivors of Trauma". This study aims to test the initial efficacy of tailored online writing interventions specifically designed for sexual minority women, transgender individuals, and/or nonbinary people to target the primary outcomes: posttraumatic stress disorder (PTSD) symptom severity and hazardous drinking.
What is the current status of trial NCT05569915?
This trial is currently completed. It is a NA study. The enrollment target is 131 participants. The study started on 2023-06-01. Estimated completion is 2024-11-30.
What conditions does trial NCT05569915 study?
This clinical trial studies the following conditions: Stress Disorders, Post-Traumatic, Drinking Heavy.
What interventions are being tested in trial NCT05569915?
The interventions under investigation include: Control (BEHAVIORAL), Trauma Expressive Writing (BEHAVIORAL), Stigma Expressive Writing (BEHAVIORAL).
Who is sponsoring clinical trial NCT05569915?
This trial is sponsored by Syracuse University, which has 31 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05569915 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Stress Disorders, Post-Traumatic
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT05569915's enrollment target sits among peer trials
131 24th of 66 higher than 43 of 66 other Stress Disorders, Post-Traumatic trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Stress Disorders, Post-Traumatic trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Manage Emotions to Reduce Aggression (MERA)
RECRUITING · NA
-
SMART Therapist Training: A Hybrid Factorial-SMART Design
RECRUITING · NA
-
Postpartum Care in the NICU (PeliCaN) Transitions
RECRUITING · NA
-
Healthy Recovery After Trauma Study
RECRUITING · NA
-
Intervention to Enhance Coping and Help-seeking Among Youth in Foster Care
RECRUITING · NA
-
Whole Health in VA Mental Health: Omnis Salutis
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03051464 · 131 participants · Phase 2
No Surgery Trial / Two Dose-escalation Strategies
- NCT04301843 · 131 participants · Phase 2
Eflornithine (DFMO) and Etoposide for Relapsed/Refractory Neuroblastoma
- NCT04748549 · 131 participants · NA
Intraoperative VR for Older Patients Undergoing TKA
- NCT05951179 · 131 participants · Phase 2
Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI